Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00002135 · ClinicalTrials.gov registry record · NA
An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access
A NA study, sponsored by Hoffmann-La Roche.
- Completed
- Registry status
- NA
- Development phase
NCT00002135: Completed NA study, sponsored by Hoffmann-La Roche.
NCT00002135 is a NA study that has completed, run by Hoffmann-La Roche. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00002135, a NA study, has completed, sponsored by Hoffmann-La Roche.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
To provide oral ganciclovir to patients who require maintenance for control of cytomegalovirus (CMV) retinitis, but who lack patent permanent central venous access for long-term administration of intravenous drugs.
Interventions
- DRUG Ganciclovir
Trial Details
| Field | Value |
|---|---|
| Phase | NA |
What the finished NCT00002135 record still lists
NCT00002135 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which Ganciclovir is the first listed.
NCT00002135 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00002135 about?
NCT00002135 is a clinical study titled "An Open-Label Safety Study of Oral Ganciclovir Maintenance Treatment of CMV Retinitis in People With Limited Venous Access". To provide oral ganciclovir to patients who require maintenance for control of cytomegalovirus (CMV) retinitis, but who lack patent permanent central venous access for long-term administration of intravenous drugs.
What is the current status of trial NCT00002135?
This trial is currently completed. It is a NA study.
What interventions are being tested in trial NCT00002135?
The interventions under investigation include: Ganciclovir (DRUG).
Who is sponsoring clinical trial NCT00002135?
This trial is sponsored by Hoffmann-La Roche, which has 909 total clinical trials registered on ClinicalTrials.gov.